Učitavanje...
Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab – a case report
Much excitement has been generated with the approval of idarucizumab, a humanized monoclonal antigen‐binding antibody fragment that is capable of reversing the anticoagulant activity of dabigatran. Here, we describe our initial experience of using tissue plasminogen activator (tPA) in an acute poste...
Spremljeno u:
| Izdano u: | Ann Clin Transl Neurol |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5099535/ https://ncbi.nlm.nih.gov/pubmed/27844035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.346 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|